Investigating the ACE2 polymorphisms in COVID-19 susceptibility: An in silico analysis
{{output}}
Background: Novel coronavirus (SARS-CoV-2) became an epidemic disease and lead to a pneumonia outbreak first in December 2019 in Wuhan, China. The symptoms related to coronavirus disease-19 (COVID-19) were different ranging from ... ...
